Auris Medical Provides Update on Tinnitus Drug Development Strategy
April 25, 2019 at 9:00 AM EDT
Hamilton, Bermuda, April 25, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical...